The global fertility services market generated $20,388.61 million in 2019 and is projected to reach $25,709.64 million by 2027, growing at a CAGR of 15.9% from 2020 to 2027. Fertility services are treatments that assist in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which aid couples with infertility problems, single mothers, and the lesbian, gay, bisexual and trans (LGBT) community to procreate.
The global fertility services market is expected to witness a substantial growth in the future, owing to high incidence of infertility cases, emerging trend of delayed pregnancies among women, rise in technological advancements in fertility procedures, and increased rate of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.
Recent innovations in IVF technology, such as embryoscope and capsule IVF, are projected to boost the demand for fertility devices in the future. However, strenuous maintenance issues, high cost of devices; multiple pregnancies, i.e., the delivery of twins, triplets, and others, associated with fertility treatments; and ethical considerations are projected to hinder the market growth. Moreover, rise in new fertility clinics and increase in same-sex marriages are projected to offer lucrative growth opportunities in future. In addition, rise in fertility tourism is expected to provide ample growth opportunities especially in the developing economies.
The global fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI (intracytoplasmic sperm injection), intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America
Europe
Asia-Pacific
LAMEA
The global fertility services market is expected to witness a substantial growth in the future, owing to high incidence of infertility cases, emerging trend of delayed pregnancies among women, rise in technological advancements in fertility procedures, and increased rate of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.
Recent innovations in IVF technology, such as embryoscope and capsule IVF, are projected to boost the demand for fertility devices in the future. However, strenuous maintenance issues, high cost of devices; multiple pregnancies, i.e., the delivery of twins, triplets, and others, associated with fertility treatments; and ethical considerations are projected to hinder the market growth. Moreover, rise in new fertility clinics and increase in same-sex marriages are projected to offer lucrative growth opportunities in future. In addition, rise in fertility tourism is expected to provide ample growth opportunities especially in the developing economies.
The global fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI (intracytoplasmic sperm injection), intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the fertility services market, and the current trends and future estimations to elucidate the imminent investment pockets
- It presents a quantitative analysis of the market from 2019 to 2027 to enable stakeholders to capitalize on the prevailing market opportunities
- Extensive analysis of the market based on procedures, services, and end users assists to understand the trends in the industry
KEY PLAYERS
and their strategies are thoroughly analyzed to understand the competitive outlook of the market
Key Market Segments
By Procedure
- IVF with ICSI
- IUI
- IVF without ICSI
- Surrogacy
- Others
By Service
- Fresh Non-donor
- Frozen Non-donor
- Egg & Embryo Banking
- Fresh Donor
- Frozen Donor
By End User
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa
List of Key Players profiled in the report
- Apollo Hospitals Enterprise Ltd
- Care Fertility Group Ltd
- Carolinas Fertility Institute
- City Fertility
- Fertility Associates Limited
- Genea Limited
- Medicover Group
- Monash IVF Group Limited
- Progyny Inc.
- Virtus Health
List of other players in the value chain (profiles not included in the report):
- INVO Bioscience
- IVFtech ApS
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: FERTILITY SERVICES MARKET, BY PROCEDURE
CHAPTER 5: FERTILITY SERVICES MARKET, BY SERVICE
CHAPTER 6: FERTILITY SERVICES MARKET, BY END USER
CHAPTER 7: FERTILITY SERVICES MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
